LIMN Stock Analysis: Buy, Sell, or Hold?
LIMN - Liminatus Pharma, Inc. Class A Common Stock
$0.13
-0.02 (-13.68%)
βΌ
5d:
+11.45%
30d:
+12.04%
90d:
-44.57%
HOLD
MODERATE Confidence
Analysis Updated: Jul 16, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When LIMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: LIMN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LIMN is currently trading at $0.13, which is considered extended relative to its 30-day fair value range of $0.11 to $0.13.
Technical Outlook: Technically, LIMN is in a strong downtrend. Immediate support is located at $0.10, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 13.7% recently.
Market Sentiment: LIMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LIMN is in a strong downtrend. Immediate support is located at $0.10, while resistance sits at $0.21. Short-term momentum is weak, with the stock down 13.7% recently.
Market Sentiment: LIMN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.11 -
$0.13
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-13.7%)
Trading Range Analysis
30-Day Trading Range
$0.11 -
$0.13
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.10
Resistance Level
$0.21
Current Trend
Strong Downtrend
Technical data as of
Jul 16, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 17, 2026 11:07 AM ET
Data refreshes hourly during market hours. Next update: 12:07 PM
Data refreshes hourly during market hours. Next update: 12:07 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical β¦ |
STRONG BUY
29 analysts |
$88 | 61 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
RNA
Atrium Therapeutics, Inc⦠|
STRONG BUY
15 analysts |
$25 | 51 HOLD |
|
GPCR
Structure Therapeutics I⦠|
STRONG BUY
14 analysts |
$105 | 48 HOLD |